CASE REPORT

JOP. J Pancreas (Online) 2005; 6(2):231-237.

Estimating the Diagnostic Accuracy of Procalcitonin as a Marker of the Severity of Acute Pancreatitis: A Meta-Analytic Approach

Nusrat Shafiq1, Samir Malhotra1, Deepak K Bhasin2, Surinder Rana2, Shabir Siddhu1, Promila Pandhi1

Departments of 1Pharmacology and 2Gastroenterology, Post Graduate Institute of Medical Education and Research. Chandigarh, India

ABSTRACT

Context Approximately 15-20% of cases of acute pancreatitis are categorized as severe. There is a lack of accurate predictors of disease severity. Several studies have evaluated the usefulness of procalcitonin as a marker of severe disease. Reports regarding the diagnostic accuracy of procalcitonin are conflicting.

Objective The present meta-analysis was carried out to evaluate the relevance of procalcitonin as a predictor of disease severity.

Methods Two investigators working independently attempted to locate eligible studies by electronic and manual means. Studies in which at least one of the markers of disease severity was procalcitonin were included for analysis. For all the studies included, the following parameters were calculated: true positive, false negative, false positive and true negative. A summary receiver operating characteristic (SROC) curve was generated from these parameters.

Results Four studies were finally included in the analysis. The unweighted regression line parameters b and i were 3.633 and 1.399, respectively. The values for b and i for weighted regression line were 3.637 and 1.428. The SROC curve generated demonstrated that procalcitonin is not a good predictor of the severity of acute pancreatitis.

Conclusion The available data indicates that procalcitonin cannot be considered a good marker for assessing the severity of pancreatitis.

Full text: HTML format  PDF format
  Look up who cited this article

References

  1. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330:1198-210. [More details]

  2. Barie PS. A critical review of antibiotic prophylaxis in severe acute pancreatitis. Am J Surg 1996; 172:38S-43S. [More details]

  3. Werner J, Hartwig W, Uhl W, Muller C, Buchler MW. Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003; 3:115-27. [More details]

  4. Kivisaari L, Somer K, Standertskjold-Nordenstam CG, Schroder T, Kivilaakso E, Lempinen M. Early detection of acute fulminant pancreatitis by contrast-enhanced computed tomography. Scand J Gastroenterol 1983; 18:39-41 [More details]

  5. London NJ, Neoptolemos JP, Lavelle J, Bailey I, James D. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 1989; 76:268-72. [More details]

  6. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139:69-81. [More details]

  7. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77:1260-4. [More details]

  8. Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol 1998; 15:202-9. [More details]

  9. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K. Outcome prediction bytraditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999; 37:363-8. [More details]

  10. Hensel M, Volk T, Docke WD, Kern F, Tschirna D, Egerer K, et al. Hyperprocalcitonemia in patients withnoninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anaesthesiology 1998; 89:93-104. [More details]

  11. Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H. Procalcitonin streip test in the early prediction of severe acute pancreatitis. Br J Surg 2001; 88:222-7. [More details]

  12. Frasquet J, Saez J, Trigo C, Martinez J, Such J, Perez-Mateo M. Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis. Br J Surg 2003; 90:1129-30. [More details]

  13. Ammori BJ, Becker KL, Kite P, Snider RH, Nylen ES, White JC, et al. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission. Br J Surg 2003; 90:197-204. [More details]

  14. Melzi D'Eril GV, Merlini G, Finazzi S, Bosoni T, Barakat B, Pezzilli R. Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complications. Clin Chem 2000; 46:428-430. [More details]

  15. Kylanpaa-Back ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppaniemi AK, Karonen SL, et al. Procalcitonin, soluble interleukin-2receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001; 29:63-9. [More details]

  16. Muller CA, Uhl W, Printzen G, Gloor B, Bischofberger H, Tcholakov O, Buchler MW. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46:233-8. [More details]

  17. Oezcueruemez-Porsch M, Kunz D, Hardt PD, Fadgyas T, Kress O, Schulz HU, et al. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998; 43:1763-9. [More details]

  18. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41:832-40. [More details]

  19. Pindak D, Parrak V, Pechan J, Vavrecka A, Kuzela L, Fuchs D, Irsakova J. The clinical value of procalcitonin in prediction of severity and outcome in acute pancreatitis. Hepatogastroenterology 2003; 50(Suppl II):28-9. [More details]

  20. Pezzilli R, Melzi d'Eril GV, Morselli-Labate AM, Merlini G, Barakat B, Bosoni T. Serum amyloid A, procalcitonin, and C-Reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000; 45:1072-8. [More details]

  21. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: A new meta-analysis method. Med Decis Making 1993; 13:313-21. [More details]

  22. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21:1237-56. [More details]

  23. Midgette AS, Stukel TA, Littenberg B. A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic-summary point estimates. Med Decis Making 1993; 13:253-7. [More details]

  24. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. In Methods for meta-analysis in medical research. John Wiley & Sons Ltd. New York. 2000 ; 205-28. [More details]

Keywords Biological Markers; Calcitonin; Meta-Analysis; ROC Curve; Pancreatitis, Acute Necrotizing; Sensitivity and Specificity

Correspondence Samir Malhotra: samirmalhotra345@yahoo.com